|Mr. Gary E. Bischoping Jr.||Sr. VP of Fin. & CFO||786.12k||N/A||1968|
|Mr. Dow R. Wilson||Pres, CEO & Director||N/A||N/A||1959|
|Mr. Patrick Joda||Sr. VP of Global Operations||N/A||N/A||1958|
|Mr. Magnus A. Momsen||Sr. VP, Chief Accounting Officer & Corp. Controller||N/A||N/A||N/A|
|Mr. J. Michael Bruff||Sr. VP of Investor Relations||N/A||N/A||1969|
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Varian Medical Systems, Inc.’s ISS Governance QualityScore as of November 1, 2018 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 4; Compensation: 7.